Mitomycin 40 Mg Inj

Mitomycin belongs to a class of chemotherapy medications known as alkylating agents, which work by cross-linking DNA strands within cancer cells, preventing them from properly replicating and dividing. This disruption ultimately leads to the destruction of rapidly dividing cancer cells, helping slow tumor growth and progression. It is commonly used in the treatment of advanced stomach and pancreatic cancer, often as part of a combination chemotherapy regimen alongside other agents. Mitomycin is also used as a direct bladder instillation treatment for superficial bladder cancer, where it is delivered directly into the bladder to help reduce the recurrence of tumors following surgical removal. The intravenous form is administered in a hospital or specialized oncology setting, allowing healthcare providers to closely monitor the patient during and after administration. Treatment schedules and dosing are carefully individualized based on the specific type and stage of cancer, as well as the patient's overall health and treatment history. Regular monitoring, including blood counts and kidney function tests, is an important part of care throughout treatment to help guide safe and effective dosing. Many patients experience meaningful tumor response and improved disease management as part of a comprehensive cancer treatment plan involving Mitomycin. As with all chemotherapy medications, Mitomycin injection should be administered under the close supervision of an experienced oncology healthcare team.